{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:52:25Z","timestamp":1790707945671,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.eururo.2012.03.031","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T16:33:44Z","timestamp":1332520424000},"page":"1157-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder"],"prefix":"10.1016","volume":"62","author":[{"given":"Youko","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Zabbarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Birder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"de Groat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann T.","family":"Hanna-Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.03.031_bib0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eururo.2012.03.031_bib0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.eururo.2012.03.031_bib0015","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor","volume":"110","author":"Rummel","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.eururo.2012.03.031_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eururo.2009.12.022","article-title":"Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder","volume":"57","author":"Coelho","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.toxicon.2009.02.021","article-title":"Botulinum toxin in the treatment of OAB, BPH, and IC","volume":"54","author":"Smith","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.eururo.2012.03.031_bib0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","article-title":"In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats","volume":"66","author":"Khera","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.03.031_bib0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.eururo.2012.03.031_bib0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0045","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpuro0672","article-title":"Mechanisms of disease: involvement of the urothelium in bladder dysfunction","volume":"4","author":"Birder","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-642-16499-6_17","article-title":"Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A","author":"Charrua","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.03.031_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1469-445X.1999.tb00078.x","article-title":"The activation of bladder wall afferent nerves","volume":"84","author":"Morrison","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0080","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.eururo.2008.11.009","article-title":"Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment","volume":"55","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0085","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.juro.2010.07.034","article-title":"Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration","volume":"184","author":"Datta","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/nau.21022","article-title":"Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target","volume":"30","author":"Ochodnicky","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2012.03.031_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.eururo.2008.05.007","article-title":"Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats","volume":"56","author":"Chuang","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0100","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.juro.2008.10.139","article-title":"Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity","volume":"181","author":"McCarthy","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0105","doi-asserted-by":"crossref","first-page":"F1065","DOI":"10.1152\/ajprenal.00229.2006","article-title":"Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists","volume":"292","author":"Kanai","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.expneurol.2009.07.016","article-title":"Neurokinins inhibit low threshold inactivating K+ currents in capsaicin responsive DRG neurons","volume":"219","author":"Sculptoreanu","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MN:34:3:243","article-title":"Is there a role for T-type calcium channels in peripheral and central pain sensitization?","volume":"34","author":"Nelson","year":"2006","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0120","doi-asserted-by":"crossref","first-page":"34846","DOI":"10.1074\/jbc.M202902200","article-title":"Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin","volume":"277","author":"Duggan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eururo.2012.03.031_bib0125","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","article-title":"Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential","volume":"29","author":"Meng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2012.03.031_bib0130","doi-asserted-by":"crossref","first-page":"F423","DOI":"10.1152\/ajprenal.00056.2003","article-title":"Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium","volume":"285","author":"Birder","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0135","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1172\/JCI24086","article-title":"ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells","volume":"115","author":"Wang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eururo.2012.03.031_bib0140","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1523\/JNEUROSCI.21-15-05670.2001","article-title":"P2X3 knock-out mice reveal a major sensory role for urothelially released ATP","volume":"21","author":"Vlaskovska","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2012.03.031_bib0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","article-title":"P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP","volume":"567","author":"Cockayne","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.eururo.2012.03.031_bib0150","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/35039519","article-title":"Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice","volume":"407","author":"Cockayne","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.03.031_bib0155","doi-asserted-by":"crossref","unstructured":"Giannantoni A, Proietti S, Vianello A, et al. Assessment of botulinum A toxin high affinity SV2 receptors on normal human urothelial cells [abstract 793]. Poster presented at: American Urological Association annual meeting; May 14\u201319, 2011; Washington, DC, USA.","DOI":"10.1016\/j.juro.2011.02.611"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812003521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812003521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:02:39Z","timestamp":1759582959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812003521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0302283812003521"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.03.031","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2012.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}